{"transactions":[{"id":2058287,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-10T02:34:46.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":93600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027."}],"balance_after":93600,"derivative":{"exercise_price":2.05,"expiration_date":"2032-12-31","underlying":"Common Stock","underlying_shares":93600},"source":{"system":"sec-edgar","filing":"0000899243-23-001404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924323001404/doc4.xml","form_type":"4"}},{"id":2433312,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-18T23:33:54.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":70967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026."}],"balance_after":70967,"derivative":{"exercise_price":11.55,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":70967},"source":{"system":"sec-edgar","filing":"0000899243-22-002206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002206/doc4.xml","form_type":"4"}},{"id":2447127,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T21:26:40.000Z","date":"2021-12-30","kind":"exercise","acquired":false,"shares":14102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 20, 2020 with a Vesting Commencement Date of June 1, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through June 1, 2024."}],"balance_after":47034,"derivative":{"exercise_price":1.56,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":14102},"source":{"system":"sec-edgar","filing":"0000899243-22-000510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322000510/doc4.xml","form_type":"4"}},{"id":2447126,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-04T21:26:40.000Z","date":"2021-12-30","kind":"exercise","acquired":true,"shares":14102,"price":1.56,"value":21999.12,"ownership":{"direct":true},"balance_after":14102,"source":{"system":"sec-edgar","filing":"0000899243-22-000510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322000510/doc4.xml","form_type":"4"}},{"id":2465013,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-12-17T21:17:23.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":135,"price":13.9736,"value":1886.436,"ownership":{"direct":false,"nature":"By The Leonard Revocable Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.93 to $13.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) of this Form 4."}],"balance_after":122157,"source":{"system":"sec-edgar","filing":"0000899243-21-048768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924321048768/doc4.xml","form_type":"4"}},{"id":2465012,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-12-17T21:17:23.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":2865,"price":13.3875,"value":38355.1875,"ownership":{"direct":false,"nature":"By The Leonard Revocable Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.84 to $13.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4."}],"balance_after":122292,"source":{"system":"sec-edgar","filing":"0000899243-21-048768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924321048768/doc4.xml","form_type":"4"}},{"id":2729222,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T20:31:08.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":27311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025."}],"balance_after":27311,"derivative":{"exercise_price":16,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":27311},"source":{"system":"sec-edgar","filing":"0000899243-21-018117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924321018117/doc4.xml","form_type":"4"}},{"id":2729221,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":120827,"kind":"person","name":"Leonard Reid","position":1,"cik":"0001857795","reported_name":"Leonard Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T20:31:08.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":99163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 8, 2020. 25% of the shares underlying the options vest on December 8, 2021, the remaining shares vest in equal monthly installments through December 8, 2024."}],"balance_after":99163,"derivative":{"exercise_price":4.77,"expiration_date":"2030-12-07","underlying":"Common Stock","underlying_shares":99163},"source":{"system":"sec-edgar","filing":"0000899243-21-018117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924321018117/doc4.xml","form_type":"4"}}]}